Fortis Healthcare (India), one of Asia's largest private healthcare providers, with a network of 62 hospitals, on Friday announced the unaudited consolidated results for the three months ended June 30, 2011.
The company reported a net profit of Rs 14 crore against a loss of Rs 14.3 crore in the corresponding period last fiscal.
In line with its strategy to expand its offerings and enhance its geographical footprint, it acquired 71.5 per cent stake in Super Religare Laboratories (SRL), one of India's leading diagnostic companies, for Rs 804 crore.
The company maintained its growth momentum during the quarter and reported consolidated operating revenue of Rs 483 crore, representing a growth of 43 per cent over the corresponding period last fiscal. This includes Rs 62 crore from the newly added diagnostic vertical (SRL).